HCA, Hospital Corporation of America Director, Oncology Early Phase Strategic Sites in Nashville, Tennessee

Sarah Cannon Research Institute (SCRI) is the research arm of HCA’s global cancer enterprise, Sarah Cannon. Focused on advancing therapies for patients, it is one of the world’s leading clinical research organizations conducting community-based clinical trials in oncology, cardiology and orthopedics through affiliations with a network of more than 1,000 physicians across the United States and United Kingdom.

We believe our success is dependent on a healthy work environment where staff members are the core of advancing therapies for patients and accelerating drug development. We apply the same compassion and commitment we have for our patients to our co-workers and colleagues and promote an entrepreneurial culture.

Summary of Key Responsibilities:Responsible for collaborative support and oversight of assigned Oncology Phase 1 Strategic Sites to ensure site goals are achieved as well as the site maintain a high level of financial and quality performance. Duties will include, but are not limited to, collaborating with site leaders and staff to enhance Phase 1 research operations, enrollment and reporting.

Duties include but are not limited to:

• Problem solves clinical situations along with research program members as they arise. • Monitors patient enrollment at sites through weekly and monthly reporting. • Assists in the creation, development and execution of SOPs, WPGs and corporate guidelines. • Assists in development and tracking of quarterly goals for each site. • Identifies opportunities and develops action plans as necessary to increase patient accrual. • Create and support strategic and tactical plans for site growth • Oversees and manages day-to-day needs of site research leaders • Attends weekly Clinical Review meetings providing insight on clinical procedures and logistics of conducting the study. • Works closely with site, sponsor/CRO monitors, and study managers to quantify the quality and timeliness of study data • Represents the company vision at the sites. • Responsible for working with the sites on individual site goals, financial performance, quality assurance, oversight and contracted patient enrollment. • Responsible for collaborative oversight of research site operations. • Coordinate and assist with the process of on-boarding and training new research sites. • Assess available research resources and facilitate those resources within each site • Assists with continuing education and training to investigators and research staff. • Meets with physicians and administrators as needed to assess performance of site. • Communicates to all stakeholders performance standards and expectations

  • Understanding of SCRI Organizational Structure and Policies Knowledge of SCRI and Site Standard Operating Procedures and systems
  • Knowledge of Clinical Research Process General Knowledge of Research Regulatory and Quality Assurance Guidelines
  • Skills in Word, Powerpoint and overall computer skills
  • Public presentation skills
  • Able to communicate via email, text and outlook meeting platforms
  • Critical thinking and problem resolution abilities Independent work ethic Ability to travel independently to collaborate with external sites
  • Associate's degree required, Bachelor's preferred
  • 1-3 years management experience required
  • 3-5 years clinical research experience in an oncology setting


Title: Director, Oncology Early Phase Strategic Sites

Location: Tennessee-Nashville-Sarah Cannon Research Institute Clinical Operations

Requisition ID: 03058-SARA